Abernathy MacGregor Group and Kekst and Company are engaged in the $1.5B acquisition of Kremers Urban Pharmaceuticals by private equity firms Advent International and Avista Capital Partners.
Kremers is a US-based generic pharma unit of Belgium's UCB, which said it is making the deal to focus on its core neurology and immunology businesses.
UCB bought the Princeton, N.J.-based Kremers Urban in 2006 when it was part of Schwarz Pharma.
Advent enlisted Abernathy MacGregor, while Kekst represents Avista on the PR front.
The deal is expected to close in the first quarter of 2015.
Spectrum Science acquires clinical trial recruitment and engagement solutions provider Continuum Clinical.
How PR agency owners can navigate the M&A process in a way that yields a rewarding experience for both owners and the teams they leave behind.
Ten potential ways an agency sale can positively benefit team members and employees.
Kekst CNC reps Palladium Equity Partners and its joint venture affiliate, Palladium Heritage, on the acquisition of National Auto Parts, USA;, NAP San Diego; and National Auto Parts-Oakland to form Collision Auto Parts, a platform serving customers in the automotive aftermarket collision repair sector.
ICR has acquired Bullfrog + Baum, the 23-year-old PR shop focused on the hospitality, lifestyle, travel and consumer marketing sectors.
Have a comment? Send it to 
No comments have been submitted for this story yet.